Perceptive-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "NUVL",
  "AXSM",
  "EWTX",
  "CNTA",
  "RGEN",
  "INSM",
  "ARGX",
  "AORT",
  "MDGL",
  "FOLD",
  "ADMA",
  "BSX",
  "MREO",
  null,
  "RCKT",
  "ADPT",
  "ATXS",
  "IMTX",
  "NRIX",
  "ACRV",
  "ADGM",
  "ALDX",
  "AVTX",
  "ATHA",
  "AMLX",
  "JANX",
  "APYX",
  "AVR",
  "APLT",
  null,
  null,
  "CTNM",
  "SYRE",
  "APGE",
  "ISRG",
  null,
  "INBX",
  "NBIX",
  "KALA",
  "LXEO",
  "NAUT",
  null,
  "OKUR",
  null,
  "IOVA",
  "BDSX",
  null,
  "IKT",
  "NBTX",
  null,
  null,
  "PODD",
  "ZYME",
  "RAPT",
  "PTGX",
  "TRAW",
  "SLDB",
  "PRAX",
  "AQST",
  "LYRA",
  "RYTM",
  "SLNO",
  "ACLX",
  "DYN",
  "SCPH",
  null,
  "DCTH",
  "EOLS",
  "EYPT",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "OBIO",
  null,
  "IMVT",
  "PCVX",
  "CRGX",
  "CELC",
  "CGEM",
  "DXCM",
  "IRON",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 86
Total Value: 2694161578
Accession Number: 0001012975-25-000242
Form Type: 13F-HR
CIK: perceptive-advisors
Manager Name: Perceptive-Advisors

Data Enrichment

87% identified

75 identified11 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

86 positions • $2.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 5

Sort by:

Verona Pharma plc

VRNA|925050106

Shares:6.6M

Value:$416.7M

% of Portfolio:15.5% ($416.7M/$2.7B)

Arcellx, Inc.

ACLX|03940C100

Shares:2.9M

Value:$192.0M

% of Portfolio:7.1% ($192.0M/$2.7B)

AMICUS THERAPEUTICS, INC.

FOLD|03152W109

Shares:21.5M

Value:$175.2M

% of Portfolio:6.5% ($175.2M/$2.7B)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:2.5M

Value:$135.0M

% of Portfolio:5.0% ($135.0M/$2.7B)

Nuvalent, Inc.

NUVL|670703107

Shares:1.6M

Value:$115.9M

% of Portfolio:4.3% ($115.9M/$2.7B)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:1.5M

Value:$107.6M

% of Portfolio:4.0% ($107.6M/$2.7B)

46116X101

Shares:786.4K

Value:$103.7M

% of Portfolio:3.9% ($103.7M/$2.7B)

MeiraGTx Holdings plc

MGTX|G59665102

Shares:12.6M

Value:$85.3M

% of Portfolio:3.2% ($85.3M/$2.7B)

ARTIVION, INC.

AORT|228903100

Shares:2.8M

Value:$68.7M

% of Portfolio:2.5% ($68.7M/$2.7B)

Aldeyra Therapeutics, Inc.

ALDX|01438T106

Shares:9.3M

Value:$53.3M

% of Portfolio:2.0% ($53.3M/$2.7B)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:1.1M

Value:$52.8M

% of Portfolio:2.0% ($52.8M/$2.7B)

Evolus, Inc.

EOLS|30052C107

Shares:4.1M

Value:$49.7M

% of Portfolio:1.8% ($49.7M/$2.7B)

Immunovant, Inc.

IMVT|45258J102

Shares:2.8M

Value:$48.6M

% of Portfolio:1.8% ($48.6M/$2.7B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:11.9M

Value:$44.1M

% of Portfolio:1.6% ($44.1M/$2.7B)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:3.0M

Value:$43.7M

% of Portfolio:1.6% ($43.7M/$2.7B)

IOVANCE BIOTHERAPEUTICS, INC.

IOVA|462260100

Shares:12.7M

Value:$42.3M

% of Portfolio:1.6% ($42.3M/$2.7B)

Immatics N.V.

IMTX|N44445109

Shares:9.4M

Value:$42.3M

% of Portfolio:1.6% ($42.3M/$2.7B)

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:1.1M

Value:$41.9M

% of Portfolio:1.6% ($41.9M/$2.7B)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:355.1K

Value:$41.4M

% of Portfolio:1.5% ($41.4M/$2.7B)

INSMED Inc

INSM|457669307

Shares:509.3K

Value:$38.9M

% of Portfolio:1.4% ($38.9M/$2.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Verona Pharma plc(VRNAcusip925050106)	6.6M	QoQ +2.67% (+171.2K) YoY +74.48% (+2.8M)	All Managers (Combined)	$416.7M	15.5% ($416.7M/$2.7B)	QoQ +40.37% (+$119.9M) YoY +588.50% (+$356.2M)
Arcellx, Inc.(ACLXcusip03940C100)	2.9M	QoQ -15.87% (-552.4K) YoY -25.60% (-1.0M)	All Managers (Combined)	$192.0M	7.1% ($192.0M/$2.7B)	QoQ -28.04% (-$74.8M) YoY -29.82% (-$81.6M)
AMICUS THERAPEUTICS, INC.(FOLDcusip03152W109)	21.5M	QoQ -11.47% (-2.8M) YoY -23.49% (-6.6M)	All Managers (Combined)	$175.2M	6.5% ($175.2M/$2.7B)	QoQ -23.31% (-$53.2M) YoY -47.00% (-$155.4M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	2.5M	QoQ -30.75% (-1.1M) YoY -22.03% (-720.1K)	All Managers (Combined)	$135.0M	5.0% ($135.0M/$2.7B)	QoQ -34.48% (-$71.0M) YoY -4.68% (-$6.6M)
Nuvalent, Inc.(NUVLcusip670703107)	1.6M	QoQ -37.63% (-986.0K) YoY -41.29% (-1.1M)	All Managers (Combined)	$115.9M	4.3% ($115.9M/$2.7B)	QoQ -43.49% (-$89.2M) YoY -44.55% (-$93.1M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	1.5M	QoQ +0.37% (+5.6K) YoY -50.99% (-1.6M)	All Managers (Combined)	$107.6M	4.0% ($107.6M/$2.7B)	QoQ +59.54% (+$40.2M) YoY -18.19% (-$23.9M)
(cusip46116X101)✕	786.4K	QoQ -38.96% (-502.0K) YoY -25.48% (-269.0K)	All Managers (Combined)	$103.7M	3.9% ($103.7M/$2.7B)	QoQ -3.59% (-$3.9M) YoY +42.04% (-$30.7M)
MeiraGTx Holdings plc(MGTXcusipG59665102)	12.6M	QoQ 0.00% (+0) YoY +11.03% (+1.3M)	All Managers (Combined)	$85.3M	3.2% ($85.3M/$2.7B)	QoQ +11.32% (+$8.7M) YoY +24.05% (+$16.5M)
ARTIVION, INC.(AORTcusip228903100)	2.8M	QoQ 0.00% (-0) YoY +4.67% (+124.7K)	All Managers (Combined)	$68.7M	2.5% ($68.7M/$2.7B)	QoQ -14.02% (-$11.2M) YoY +21.59% (+$12.2M)
Aldeyra Therapeutics, Inc.(ALDXcusip01438T106)	9.3M	QoQ 0.00% (+0) YoY +7.93% (+682.3K)	All Managers (Combined)	$53.3M	2.0% ($53.3M/$2.7B)	QoQ +15.23% (+$7.0M) YoY +89.80% (+$25.2M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	1.1M	QoQ -14.18% (-180.4K) YoY +9.75% (+96.9K)	All Managers (Combined)	$52.8M	2.0% ($52.8M/$2.7B)	QoQ +7.51% (-$3.7M) YoY +83.46% (+$24.0M)
Evolus, Inc.(EOLScusip30052C107)	4.1M	QoQ -19.75% (-1.0M) YoY -28.23% (-1.6M)	All Managers (Combined)	$49.7M	1.8% ($49.7M/$2.7B)	QoQ -12.56% (-$7.1M) YoY -38.33% (-$30.9M)
Immunovant, Inc.(IMVTcusip45258J102)	2.8M	QoQ +32.95% (-704.9K) YoY +2744.07% (+2.7M)	All Managers (Combined)	$48.6M	1.8% ($48.6M/$2.7B)	QoQ -8.27% (-$4.4M) YoY +1404.33% (+$45.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	11.9M	QoQ +72.39% (+5.0M) YoY +72.39% (-5.0M)	All Managers (Combined)	$44.1M	1.6% ($44.1M/$2.7B)	QoQ +59.46% (+$16.4M) YoY -52.11% (-$47.9M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	3.0M	QoQ -52.11% (-3.3M) YoY -1.39% (-42.9K)	All Managers (Combined)	$43.7M	1.6% ($43.7M/$2.7B)	QoQ -58.88% (-$62.6M) YoY +25.48% (-$8.9M)
IOVANCE BIOTHERAPEUTICS, INC.(IOVAcusip462260100)	12.7M	QoQ -42.51% (-9.4M) YoY -34.04% (-6.6M)	All Managers (Combined)	$42.3M	1.6% ($42.3M/$2.7B)	QoQ -74.13% (-$121.3M) YoY -85.17% (-$243.3M)
Immatics N.V.(IMTXcusipN44445109)	9.4M	QoQ 0.00% (-0) YoY +104.77% (-4.8M)	All Managers (Combined)	$42.3M	1.6% ($42.3M/$2.7B)	QoQ -36.56% (-$24.4M) YoY -12.12% (-$5.8M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	1.1M	QoQ +7.21% (-75.5K) YoY -45.50% (-937.6K)	All Managers (Combined)	$41.9M	1.6% ($41.9M/$2.7B)	QoQ -11.57% (-$5.5M) YoY -69.36% (-$95.0M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	355.1K	QoQ -46.52% (-309.0K) YoY -67.87% (-750.2K)	All Managers (Combined)	$41.4M	1.5% ($41.4M/$2.7B)	QoQ -26.28% (-$14.8M) YoY -53.04% (-$46.8M)
INSMED Inc(INSMcusip457669307)	509.3K	QoQ +253.68% (+365.3K) YoY NEW(+509.3K)	All Managers (Combined)	$38.9M	1.4% ($38.9M/$2.7B)	QoQ +290.82% (+$28.9M) YoY NEW(+$38.9M)